Short Term Follow-up of Patient Implanted With the Metatarso-Phalangeal Prosthesis METIS®
NCT ID: NCT01284985
Last Updated: 2014-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2009-02-28
2013-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this study is to have an overview of clinical status of the patient implanted with the METIS® prosthesis at short term (2 years of follow-up). The objective of this study is to evaluate the safety and efficacy of the Metatarso-Phalangeal prosthesis METIS® at short term follow up.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Study: The Effect on Clinical Outcome After Treatment of MTP Cartilage Lesions in Hallux Valgus Surgery
NCT04716140
Surgical Treatment for Hallux Rigidus
NCT01048450
Artelon Metatarsophalangeal (MTP) Spacer
NCT01028469
Synthetic Cartilage Implant Versus Interposition Arthroplasty in Hallux Rigidus Treatment: A Randomized Clinical Trial
NCT05518721
Mid-term Outcomes of First MTP Arthroplasty With Primus™ FGT Implant.
NCT02350881
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
METIS
Patient who has an indication of : Hallux Rigidus, Hallux Limitus with degenerative joint disease, Painful Hallux Valgus, Osteoarthritis, Rheumatoid arthritis, Post-traumatic arthritis and for which surgeon has recommended that a METIS® prosthesis be implanted.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have willingness to give his/her data transfer authorisation;
* has an indication of: Hallux Rigidus, Hallux Limitus with degenerative joint disease, Painful Hallux Valgus, Osteoarthritis, Rheumatoid arthritis, Post-traumatic arthritis, for which surgeon has recommended that a METIS® prosthesis be implanted
Exclusion Criteria
* excessive bone loss, bone deficiency or rapid joint destruction;
* suspected or documented metal allergy or intolerance;
* metatarsal head or phalangeal avascular necrosis;
* joint instability involving soft and fibrous tissue deficiency;
* severe metatarso-phalangeal axis deviation (Hallux Valgus angle \> 20°);
* prior mental illness or patient demonstrates that their mental capacity may interfere with their ability to follow the study protocol;
* a previous joint replacement.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Integra LifeSciences Services
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nemocnice Havlíčkův Brod
Havlíčkův Brod, , Czechia
Medisch Centrum Alkmaar
Alkmaar, , Netherlands
The Netcare and Linksfield Medical Centre
Johannesburg, , South Africa
Hospital clinico y provincial
Barcelona, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECON-EMEA-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.